{"trigger": ["<extra_id_0> IL-10 <extra_id_2> Protein <extra_id_1> Production by Th1 Cells Requires <extra_id_0> ERK1 <extra_id_2> Protein <extra_id_1> and <extra_id_0> ERK2 <extra_id_2> Protein <extra_id_1> Activation", "IL-10 <extra_id_0> Production <extra_id_2> Gene_expression <extra_id_1> by Th1 Cells <extra_id_0> Requires <extra_id_2> Positive_regulation <extra_id_1> ERK1 and ERK2 <extra_id_0> Activation <extra_id_2> Positive_regulation <extra_id_1>"], "relation": [["IL-10 <extra_id_0> Production <extra_id_2> Gene_expression <extra_id_1> by Th1 Cells Requires ERK1 and ERK2 Activation", "<extra_id_0> IL-10 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> Production by Th1 Cells Requires ERK1 and ERK2 Activation"], ["IL-10 Production by Th1 Cells <extra_id_0> Requires <extra_id_2> Positive_regulation <extra_id_1> ERK1 and ERK2 Activation", "IL-10 Production by Th1 Cells Requires ERK1 and ERK2 Activation"], ["IL-10 Production by Th1 Cells Requires ERK1 and ERK2 <extra_id_0> Activation <extra_id_2> Positive_regulation <extra_id_1>", "IL-10 Production by Th1 Cells Requires <extra_id_0> ERK1 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> and <extra_id_0> ERK2 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> Activation"]]}
{"trigger": ["Our data showed that the maintenance of <extra_id_0> IL-10 <extra_id_2> Protein <extra_id_1> induction in Th1 cells required stimulation with high antigen dose , which to some extent could be compensated for by the addition of <extra_id_0> IL-12 <extra_id_2> Protein <extra_id_1> .", "Our data showed that the <extra_id_0> maintenance <extra_id_2> Positive_regulation <extra_id_1> of IL-10 <extra_id_0> induction <extra_id_2> Gene_expression <extra_id_1> in Th1 cells <extra_id_0> required <extra_id_2> Positive_regulation <extra_id_1> stimulation with high antigen dose , which to some extent could be compensated for by the <extra_id_0> addition <extra_id_2> Positive_regulation <extra_id_1> of IL-12 ."], "relation": [["Our data showed that the <extra_id_0> maintenance <extra_id_2> Positive_regulation <extra_id_1> of IL-10 induction in Th1 cells required stimulation with high antigen dose , which to some extent could be compensated for by the addition of IL-12 .", "Our data showed that the maintenance of IL-10 <extra_id_0> induction <extra_id_2> Gene_expression <extra_id_2> Theme <extra_id_1> in Th1 cells required stimulation with high antigen dose , which to some extent could be compensated for by the addition of IL-12 ."], ["Our data showed that the maintenance of IL-10 <extra_id_0> induction <extra_id_2> Gene_expression <extra_id_1> in Th1 cells required stimulation with high antigen dose , which to some extent could be compensated for by the addition of IL-12 .", "Our data showed that the maintenance of <extra_id_0> IL-10 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> induction in Th1 cells required stimulation with high antigen dose , which to some extent could be compensated for by the addition of IL-12 ."], ["Our data showed that the maintenance of IL-10 induction in Th1 cells <extra_id_0> required <extra_id_2> Positive_regulation <extra_id_1> stimulation with high antigen dose , which to some extent could be compensated for by the addition of IL-12 .", "Our data showed that the <extra_id_0> maintenance <extra_id_2> Positive_regulation <extra_id_2> Theme <extra_id_1> of IL-10 induction in Th1 cells required stimulation with high antigen dose , which to some extent could be compensated for by the addition of IL-12 ."], ["Our data showed that the maintenance of IL-10 induction in Th1 cells required stimulation with high antigen dose , which to some extent could be compensated for by the <extra_id_0> addition <extra_id_2> Positive_regulation <extra_id_1> of IL-12 .", "Our data showed that the maintenance of IL-10 induction in Th1 cells required stimulation with high antigen dose , which to some extent could be compensated for by the addition of <extra_id_0> IL-12 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> ."]]}
{"trigger": ["Signaling through the TCR with high doses of antigen induced stronger <extra_id_0> ERK1 <extra_id_2> Protein <extra_id_1> and <extra_id_0> ERK2 <extra_id_2> Protein <extra_id_1> activation than that induced by low antigen dose , not only in naive <extra_id_0> CD4 <extra_id_2> Protein <extra_id_1> + Tcells ( data not shown ) as previously demonstrated ( Jorritsma etal . , 2003 ) but also in <extra_id_0> CD4 <extra_id_2> Protein <extra_id_1> + Tcells restimulated with the same high and low antigen doses ( Figure5A ) .", "Signaling through the TCR with high doses of antigen <extra_id_0> induced <extra_id_2> Positive_regulation <extra_id_1> stronger ERK1 and ERK2 <extra_id_0> activation <extra_id_2> Positive_regulation <extra_id_1> than that <extra_id_0> induced <extra_id_2> Positive_regulation <extra_id_1> by low antigen dose , not only in naive CD4 + Tcells ( data not shown ) as previously demonstrated ( Jorritsma etal . , 2003 ) but also in CD4 + Tcells restimulated with the same high and low antigen doses ( Figure5A ) ."], "relation": [["Signaling through the TCR with high doses of antigen <extra_id_0> induced <extra_id_2> Positive_regulation <extra_id_1> stronger ERK1 and ERK2 activation than that induced by low antigen dose , not only in naive CD4 + Tcells ( data not shown ) as previously demonstrated ( Jorritsma etal . , 2003 ) but also in CD4 + Tcells restimulated with the same high and low antigen doses ( Figure5A ) .", "Signaling through the TCR with high doses of antigen induced stronger ERK1 and ERK2 <extra_id_0> activation <extra_id_2> Positive_regulation <extra_id_2> Theme <extra_id_1> activation <extra_id_2> Positive_regulation <extra_id_2> Theme <extra_id_1> than that induced by low antigen dose , not only in naive CD4 + Tcells ( data not shown ) as previously demonstrated ( Jorritsma etal . , 2003 ) but also in CD4 + Tcells restimulated with the same high and low antigen doses ( Figure5A ) ."], ["Signaling through the TCR with high doses of antigen induced stronger ERK1 and ERK2 <extra_id_0> activation <extra_id_2> Positive_regulation <extra_id_1> than that induced by low antigen dose , not only in naive CD4 + Tcells ( data not shown ) as previously demonstrated ( Jorritsma etal . , 2003 ) but also in CD4 + Tcells restimulated with the same high and low antigen doses ( Figure5A ) .", "Signaling through the TCR with high doses of antigen induced stronger <extra_id_0> ERK1 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> and <extra_id_0> ERK2 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> activation than that induced by low antigen dose , not only in naive CD4 + Tcells ( data not shown ) as previously demonstrated ( Jorritsma etal . , 2003 ) but also in CD4 + Tcells restimulated with the same high and low antigen doses ( Figure5A ) ."], ["Signaling through the TCR with high doses of antigen induced stronger ERK1 and ERK2 activation than that <extra_id_0> induced <extra_id_2> Positive_regulation <extra_id_1> by low antigen dose , not only in naive CD4 + Tcells ( data not shown ) as previously demonstrated ( Jorritsma etal . , 2003 ) but also in CD4 + Tcells restimulated with the same high and low antigen doses ( Figure5A ) .", "Signaling through the TCR with high doses of antigen induced stronger ERK1 and ERK2 <extra_id_0> activation <extra_id_2> Positive_regulation <extra_id_2> Theme <extra_id_1> activation <extra_id_2> Positive_regulation <extra_id_2> Theme <extra_id_1> than that induced by low antigen dose , not only in naive CD4 + Tcells ( data not shown ) as previously demonstrated ( Jorritsma etal . , 2003 ) but also in CD4 + Tcells restimulated with the same high and low antigen doses ( Figure5A ) ."]]}
{"trigger": ["Although the apparent peak and amount of <extra_id_0> ERK1 <extra_id_2> Protein <extra_id_1> and <extra_id_0> ERK2 <extra_id_2> Protein <extra_id_1> activation varied slightly between experiments , a consistent finding was that high antigen dose differentiated Th1 cells always showed enhanced and prolonged <extra_id_0> ERK1 <extra_id_2> Protein <extra_id_1> and <extra_id_0> ERK2 <extra_id_2> Protein <extra_id_1> activation in the presence of <extra_id_0> IL-12 <extra_id_2> Protein <extra_id_1> , regardless of whether they were restimulated with high or low antigen dose ( Figure5B ) .", "Although the apparent peak and amount of ERK1 and ERK2 <extra_id_0> activation <extra_id_2> Positive_regulation <extra_id_1> varied slightly between experiments , a consistent finding was that high antigen dose differentiated Th1 cells always showed <extra_id_0> enhanced <extra_id_2> Positive_regulation <extra_id_1> and <extra_id_0> prolonged <extra_id_2> Positive_regulation <extra_id_1> ERK1 and ERK2 <extra_id_0> activation <extra_id_2> Positive_regulation <extra_id_1> in the presence of IL-12 , regardless of whether they were restimulated with high or low antigen dose ( Figure5B ) ."], "relation": [["Although the apparent peak and amount of ERK1 and ERK2 <extra_id_0> activation <extra_id_2> Positive_regulation <extra_id_1> varied slightly between experiments , a consistent finding was that high antigen dose differentiated Th1 cells always showed enhanced and prolonged ERK1 and ERK2 activation in the presence of IL-12 , regardless of whether they were restimulated with high or low antigen dose ( Figure5B ) .", "Although the apparent peak and amount of <extra_id_0> ERK1 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> and <extra_id_0> ERK2 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> activation varied slightly between experiments , a consistent finding was that high antigen dose differentiated Th1 cells always showed enhanced and prolonged ERK1 and ERK2 activation in the presence of IL-12 , regardless of whether they were restimulated with high or low antigen dose ( Figure5B ) ."], ["Although the apparent peak and amount of ERK1 and ERK2 activation varied slightly between experiments , a consistent finding was that high antigen dose differentiated Th1 cells always showed <extra_id_0> enhanced <extra_id_2> Positive_regulation <extra_id_1> and prolonged ERK1 and ERK2 activation in the presence of IL-12 , regardless of whether they were restimulated with high or low antigen dose ( Figure5B ) .", "Although the apparent peak and amount of ERK1 and ERK2 activation varied slightly between experiments , a consistent finding was that high antigen dose differentiated Th1 cells always showed enhanced and prolonged ERK1 and ERK2 <extra_id_0> activation <extra_id_2> Positive_regulation <extra_id_2> Theme <extra_id_1> activation <extra_id_2> Positive_regulation <extra_id_2> Theme <extra_id_1> in the presence of <extra_id_0> IL-12 <extra_id_2> Protein <extra_id_2> Cause <extra_id_1> , regardless of whether they were restimulated with high or low antigen dose ( Figure5B ) ."], ["Although the apparent peak and amount of ERK1 and ERK2 activation varied slightly between experiments , a consistent finding was that high antigen dose differentiated Th1 cells always showed enhanced and <extra_id_0> prolonged <extra_id_2> Positive_regulation <extra_id_1> ERK1 and ERK2 activation in the presence of IL-12 , regardless of whether they were restimulated with high or low antigen dose ( Figure5B ) .", "Although the apparent peak and amount of ERK1 and ERK2 activation varied slightly between experiments , a consistent finding was that high antigen dose differentiated Th1 cells always showed enhanced and prolonged ERK1 and ERK2 <extra_id_0> activation <extra_id_2> Positive_regulation <extra_id_2> Theme <extra_id_1> activation <extra_id_2> Positive_regulation <extra_id_2> Theme <extra_id_1> in the presence of IL-12 , regardless of whether they were restimulated with high or low antigen dose ( Figure5B ) ."], ["Although the apparent peak and amount of ERK1 and ERK2 activation varied slightly between experiments , a consistent finding was that high antigen dose differentiated Th1 cells always showed enhanced and prolonged ERK1 and ERK2 <extra_id_0> activation <extra_id_2> Positive_regulation <extra_id_1> in the presence of IL-12 , regardless of whether they were restimulated with high or low antigen dose ( Figure5B ) .", "Although the apparent peak and amount of ERK1 and ERK2 activation varied slightly between experiments , a consistent finding was that high antigen dose differentiated Th1 cells always showed enhanced and prolonged <extra_id_0> ERK1 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> and <extra_id_0> ERK2 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> activation in the presence of IL-12 , regardless of whether they were restimulated with high or low antigen dose ( Figure5B ) ."]]}
{"trigger": ["We then investigated whether <extra_id_0> ERK1 <extra_id_2> Protein <extra_id_1> and <extra_id_0> ERK2 <extra_id_2> Protein <extra_id_1> activation was required for the induction of <extra_id_0> IL-10 <extra_id_2> Protein <extra_id_1> in Th1 cells by using U0126 ( Figure5C ) , a compound that blocks downstream ERK activation .", "We then investigated whether ERK1 and ERK2 <extra_id_0> activation <extra_id_2> Positive_regulation <extra_id_1> was <extra_id_0> required <extra_id_2> Positive_regulation <extra_id_1> for the <extra_id_0> induction <extra_id_2> Positive_regulation <extra_id_1> of IL-10 in Th1 cells by using U0126 ( Figure5C ) , a compound that blocks downstream ERK activation ."], "relation": [["We then investigated whether ERK1 and ERK2 <extra_id_0> activation <extra_id_2> Positive_regulation <extra_id_1> was required for the induction of IL-10 in Th1 cells by using U0126 ( Figure5C ) , a compound that blocks downstream ERK activation .", "We then investigated whether <extra_id_0> ERK1 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> and <extra_id_0> ERK2 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> activation was required for the induction of IL-10 in Th1 cells by using U0126 ( Figure5C ) , a compound that blocks downstream ERK activation ."], ["We then investigated whether ERK1 and ERK2 activation was <extra_id_0> required <extra_id_2> Positive_regulation <extra_id_1> for the induction of IL-10 in Th1 cells by using U0126 ( Figure5C ) , a compound that blocks downstream ERK activation .", "We then investigated whether ERK1 and ERK2 <extra_id_0> activation <extra_id_2> Positive_regulation <extra_id_2> Cause <extra_id_1> activation <extra_id_2> Positive_regulation <extra_id_2> Cause <extra_id_1> was required for the <extra_id_0> induction <extra_id_2> Positive_regulation <extra_id_2> Theme <extra_id_1> of IL-10 in Th1 cells by using U0126 ( Figure5C ) , a compound that blocks downstream ERK activation ."], ["We then investigated whether ERK1 and ERK2 activation was required for the <extra_id_0> induction <extra_id_2> Positive_regulation <extra_id_1> of IL-10 in Th1 cells by using U0126 ( Figure5C ) , a compound that blocks downstream ERK activation .", "We then investigated whether ERK1 and ERK2 activation was required for the induction of <extra_id_0> IL-10 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> in Th1 cells by using U0126 ( Figure5C ) , a compound that blocks downstream ERK activation ."]]}
{"trigger": ["To ensure that only Tcell signaling was being affected by U0126 , we used an APC-free system in which the Tcells were differentiated in the presence of increasing doses of anti - <extra_id_0> CD3 <extra_id_2> Protein <extra_id_1> and a constant amount of <extra_id_0> IL-12 <extra_id_2> Protein <extra_id_1> .", "To ensure that only Tcell signaling was being affected by U0126 , we used an APC-free system in which the Tcells were differentiated in the presence of increasing doses of anti - CD3 and a constant amount of IL-12 ."], "relation": []}
{"trigger": ["As in the APC - driven cultures , stronger TCR stimulation together with <extra_id_0> IL-12 <extra_id_2> Protein <extra_id_1> led to higher percentages of cells producing both <extra_id_0> IL-10 <extra_id_2> Protein <extra_id_1> and <extra_id_0> IFN-gamma <extra_id_2> Protein <extra_id_1> after 1 week of culture ( Figure5C ) .", "As in the APC - driven cultures , stronger TCR stimulation together with IL-12 led to higher percentages of cells <extra_id_0> producing <extra_id_2> Gene_expression <extra_id_1> both IL-10 and IFN-gamma after 1 week of culture ( Figure5C ) ."], "relation": [["As in the APC - driven cultures , stronger TCR stimulation together with IL-12 led to higher percentages of cells <extra_id_0> producing <extra_id_2> Gene_expression <extra_id_1> both IL-10 and IFN-gamma after 1 week of culture ( Figure5C ) .", "As in the APC - driven cultures , stronger TCR stimulation together with IL-12 led to higher percentages of cells producing both <extra_id_0> IL-10 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> and <extra_id_0> IFN-gamma <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> after 1 week of culture ( Figure5C ) ."]]}
{"trigger": ["Addition of U0126 to the cultures abrogated the production of <extra_id_0> IL-10 <extra_id_2> Protein <extra_id_1> at all doses of anti - <extra_id_0> CD3 <extra_id_2> Protein <extra_id_1> ( Figure5C ) .", "Addition of U0126 to the cultures <extra_id_0> abrogated <extra_id_2> Negative_regulation <extra_id_1> the <extra_id_0> production <extra_id_2> Gene_expression <extra_id_1> of IL-10 at all doses of anti - CD3 ( Figure5C ) ."], "relation": [["Addition of U0126 to the cultures <extra_id_0> abrogated <extra_id_2> Negative_regulation <extra_id_1> the production of IL-10 at all doses of anti - CD3 ( Figure5C ) .", "Addition of U0126 to the cultures abrogated the <extra_id_0> production <extra_id_2> Gene_expression <extra_id_2> Theme <extra_id_1> of IL-10 at all doses of anti - CD3 ( Figure5C ) ."], ["Addition of U0126 to the cultures abrogated the <extra_id_0> production <extra_id_2> Gene_expression <extra_id_1> of IL-10 at all doses of anti - CD3 ( Figure5C ) .", "Addition of U0126 to the cultures abrogated the production of <extra_id_0> IL-10 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> at all doses of anti - CD3 ( Figure5C ) ."]]}
{"trigger": ["Because U0126 inhibits the <extra_id_0> MEK5 <extra_id_2> Protein <extra_id_1> - catalyzed activation of <extra_id_0> ERK5 <extra_id_2> Protein <extra_id_1> , as well as the <extra_id_0> MEK1 <extra_id_2> Protein <extra_id_1> - and <extra_id_0> MEK2 <extra_id_2> Protein <extra_id_1> - catalyzed activation of <extra_id_0> ERK1 <extra_id_2> Protein <extra_id_1> and <extra_id_0> ERK2 <extra_id_2> Protein <extra_id_1> ( Bain etal . , 2007 ; Mody etal . , 2001 ) , we also used the more specific , structurally unrelated <extra_id_0> MEK1 <extra_id_2> Protein <extra_id_1> and <extra_id_0> MEK2 <extra_id_2> Protein <extra_id_1> inhibitor PD184352 at concentrations in which it inhibits <extra_id_0> MEK1 <extra_id_2> Protein <extra_id_1> and <extra_id_0> MEK2 <extra_id_2> Protein <extra_id_1> but not <extra_id_0> MEK5 <extra_id_2> Protein <extra_id_1> ( Bain etal . , 2007 ; Mody etal . , 2001 ) .", "Because U0126 <extra_id_0> inhibits <extra_id_2> Negative_regulation <extra_id_1> the MEK5 - <extra_id_0> catalyzed <extra_id_2> Positive_regulation <extra_id_1> <extra_id_0> activation <extra_id_2> Positive_regulation <extra_id_1> of ERK5 , as well as the MEK1 - and MEK2 - <extra_id_0> catalyzed <extra_id_2> Positive_regulation <extra_id_1> <extra_id_0> activation <extra_id_2> Positive_regulation <extra_id_1> of ERK1 and ERK2 ( Bain etal . , 2007 ; Mody etal . , 2001 ) , we also used the more specific , structurally unrelated MEK1 and MEK2 <extra_id_0> inhibitor <extra_id_2> Negative_regulation <extra_id_1> PD184352 at concentrations in which it <extra_id_0> inhibits <extra_id_2> Negative_regulation <extra_id_1> MEK1 and MEK2 but not MEK5 ( Bain etal . , 2007 ; Mody etal . , 2001 ) ."], "relation": [["Because U0126 <extra_id_0> inhibits <extra_id_2> Negative_regulation <extra_id_1> the MEK5 - catalyzed activation of ERK5 , as well as the MEK1 - and MEK2 - catalyzed activation of ERK1 and ERK2 ( Bain etal . , 2007 ; Mody etal . , 2001 ) , we also used the more specific , structurally unrelated MEK1 and MEK2 inhibitor PD184352 at concentrations in which it inhibits MEK1 and MEK2 but not MEK5 ( Bain etal . , 2007 ; Mody etal . , 2001 ) .", "Because U0126 inhibits the MEK5 - <extra_id_0> catalyzed <extra_id_2> Positive_regulation <extra_id_2> Theme <extra_id_1> activation of ERK5 , as well as the MEK1 - and MEK2 - <extra_id_0> catalyzed <extra_id_2> Positive_regulation <extra_id_2> Theme <extra_id_1> catalyzed <extra_id_2> Positive_regulation <extra_id_2> Theme <extra_id_1> catalyzed <extra_id_2> Positive_regulation <extra_id_2> Theme <extra_id_1> catalyzed <extra_id_2> Positive_regulation <extra_id_2> Theme <extra_id_1> activation of ERK1 and ERK2 ( Bain etal . , 2007 ; Mody etal . , 2001 ) , we also used the more specific , structurally unrelated MEK1 and MEK2 inhibitor PD184352 at concentrations in which it inhibits MEK1 and MEK2 but not MEK5 ( Bain etal . , 2007 ; Mody etal . , 2001 ) ."], ["Because U0126 inhibits the MEK5 - <extra_id_0> catalyzed <extra_id_2> Positive_regulation <extra_id_1> activation of ERK5 , as well as the MEK1 - and MEK2 - catalyzed activation of ERK1 and ERK2 ( Bain etal . , 2007 ; Mody etal . , 2001 ) , we also used the more specific , structurally unrelated MEK1 and MEK2 inhibitor PD184352 at concentrations in which it inhibits MEK1 and MEK2 but not MEK5 ( Bain etal . , 2007 ; Mody etal . , 2001 ) .", "Because U0126 inhibits the <extra_id_0> MEK5 <extra_id_2> Protein <extra_id_2> Cause <extra_id_1> - catalyzed <extra_id_0> activation <extra_id_2> Positive_regulation <extra_id_2> Theme <extra_id_1> of ERK5 , as well as the MEK1 - and MEK2 - catalyzed activation of ERK1 and ERK2 ( Bain etal . , 2007 ; Mody etal . , 2001 ) , we also used the more specific , structurally unrelated MEK1 and MEK2 inhibitor PD184352 at concentrations in which it inhibits MEK1 and MEK2 but not MEK5 ( Bain etal . , 2007 ; Mody etal . , 2001 ) ."], ["Because U0126 inhibits the MEK5 - catalyzed <extra_id_0> activation <extra_id_2> Positive_regulation <extra_id_1> of ERK5 , as well as the MEK1 - and MEK2 - catalyzed activation of ERK1 and ERK2 ( Bain etal . , 2007 ; Mody etal . , 2001 ) , we also used the more specific , structurally unrelated MEK1 and MEK2 inhibitor PD184352 at concentrations in which it inhibits MEK1 and MEK2 but not MEK5 ( Bain etal . , 2007 ; Mody etal . , 2001 ) .", "Because U0126 inhibits the MEK5 - catalyzed activation of <extra_id_0> ERK5 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> , as well as the MEK1 - and MEK2 - catalyzed activation of ERK1 and ERK2 ( Bain etal . , 2007 ; Mody etal . , 2001 ) , we also used the more specific , structurally unrelated MEK1 and MEK2 inhibitor PD184352 at concentrations in which it inhibits MEK1 and MEK2 but not MEK5 ( Bain etal . , 2007 ; Mody etal . , 2001 ) ."], ["Because U0126 inhibits the MEK5 - catalyzed activation of ERK5 , as well as the MEK1 - and MEK2 - <extra_id_0> catalyzed <extra_id_2> Positive_regulation <extra_id_1> activation of ERK1 and ERK2 ( Bain etal . , 2007 ; Mody etal . , 2001 ) , we also used the more specific , structurally unrelated MEK1 and MEK2 inhibitor PD184352 at concentrations in which it inhibits MEK1 and MEK2 but not MEK5 ( Bain etal . , 2007 ; Mody etal . , 2001 ) .", "Because U0126 inhibits the MEK5 - catalyzed activation of ERK5 , as well as the <extra_id_0> MEK1 <extra_id_2> Protein <extra_id_2> Cause <extra_id_1> - and <extra_id_0> MEK2 <extra_id_2> Protein <extra_id_2> Cause <extra_id_1> - catalyzed <extra_id_0> activation <extra_id_2> Positive_regulation <extra_id_2> Theme <extra_id_1> activation <extra_id_2> Positive_regulation <extra_id_2> Theme <extra_id_1> of ERK1 and ERK2 ( Bain etal . , 2007 ; Mody etal . , 2001 ) , we also used the more specific , structurally unrelated MEK1 and MEK2 inhibitor PD184352 at concentrations in which it inhibits MEK1 and MEK2 but not MEK5 ( Bain etal . , 2007 ; Mody etal . , 2001 ) ."], ["Because U0126 inhibits the MEK5 - catalyzed activation of ERK5 , as well as the MEK1 - and MEK2 - catalyzed <extra_id_0> activation <extra_id_2> Positive_regulation <extra_id_1> of ERK1 and ERK2 ( Bain etal . , 2007 ; Mody etal . , 2001 ) , we also used the more specific , structurally unrelated MEK1 and MEK2 inhibitor PD184352 at concentrations in which it inhibits MEK1 and MEK2 but not MEK5 ( Bain etal . , 2007 ; Mody etal . , 2001 ) .", "Because U0126 inhibits the MEK5 - catalyzed activation of ERK5 , as well as the MEK1 - and MEK2 - catalyzed activation of <extra_id_0> ERK1 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> and <extra_id_0> ERK2 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> ( Bain etal . , 2007 ; Mody etal . , 2001 ) , we also used the more specific , structurally unrelated MEK1 and MEK2 inhibitor PD184352 at concentrations in which it inhibits MEK1 and MEK2 but not MEK5 ( Bain etal . , 2007 ; Mody etal . , 2001 ) ."], ["Because U0126 inhibits the MEK5 - catalyzed activation of ERK5 , as well as the MEK1 - and MEK2 - catalyzed activation of ERK1 and ERK2 ( Bain etal . , 2007 ; Mody etal . , 2001 ) , we also used the more specific , structurally unrelated MEK1 and MEK2 <extra_id_0> inhibitor <extra_id_2> Negative_regulation <extra_id_1> PD184352 at concentrations in which it inhibits MEK1 and MEK2 but not MEK5 ( Bain etal . , 2007 ; Mody etal . , 2001 ) .", "Because U0126 inhibits the MEK5 - catalyzed activation of ERK5 , as well as the MEK1 - and MEK2 - catalyzed activation of ERK1 and ERK2 ( Bain etal . , 2007 ; Mody etal . , 2001 ) , we also used the more specific , structurally unrelated <extra_id_0> MEK1 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> and <extra_id_0> MEK2 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> inhibitor PD184352 at concentrations in which it inhibits MEK1 and MEK2 but not MEK5 ( Bain etal . , 2007 ; Mody etal . , 2001 ) ."], ["Because U0126 inhibits the MEK5 - catalyzed activation of ERK5 , as well as the MEK1 - and MEK2 - catalyzed activation of ERK1 and ERK2 ( Bain etal . , 2007 ; Mody etal . , 2001 ) , we also used the more specific , structurally unrelated MEK1 and MEK2 inhibitor PD184352 at concentrations in which it <extra_id_0> inhibits <extra_id_2> Negative_regulation <extra_id_1> MEK1 and MEK2 but not MEK5 ( Bain etal . , 2007 ; Mody etal . , 2001 ) .", "Because U0126 inhibits the MEK5 - catalyzed activation of ERK5 , as well as the MEK1 - and MEK2 - catalyzed activation of ERK1 and ERK2 ( Bain etal . , 2007 ; Mody etal . , 2001 ) , we also used the more specific , structurally unrelated MEK1 and MEK2 inhibitor PD184352 at concentrations in which it inhibits <extra_id_0> MEK1 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> and <extra_id_0> MEK2 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> but not <extra_id_0> MEK5 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> ( Bain etal . , 2007 ; Mody etal . , 2001 ) ."]]}
{"trigger": ["PD184352 caused a similar inhibition of <extra_id_0> IL-10 <extra_id_2> Protein <extra_id_1> production by Th1 cells in a dose - dependent fashion ( Figure5D and FigureS5A ) .", "PD184352 caused a similar <extra_id_0> inhibition <extra_id_2> Negative_regulation <extra_id_1> of IL-10 <extra_id_0> production <extra_id_2> Gene_expression <extra_id_1> by Th1 cells in a dose - dependent fashion ( Figure5D and FigureS5A ) ."], "relation": [["PD184352 caused a similar <extra_id_0> inhibition <extra_id_2> Negative_regulation <extra_id_1> of IL-10 production by Th1 cells in a dose - dependent fashion ( Figure5D and FigureS5A ) .", "PD184352 caused a similar inhibition of IL-10 <extra_id_0> production <extra_id_2> Gene_expression <extra_id_2> Theme <extra_id_1> by Th1 cells in a dose - dependent fashion ( Figure5D and FigureS5A ) ."], ["PD184352 caused a similar inhibition of IL-10 <extra_id_0> production <extra_id_2> Gene_expression <extra_id_1> by Th1 cells in a dose - dependent fashion ( Figure5D and FigureS5A ) .", "PD184352 caused a similar inhibition of <extra_id_0> IL-10 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> production by Th1 cells in a dose - dependent fashion ( Figure5D and FigureS5A ) ."]]}
{"trigger": ["Upon addition of inhibitors to othersignaling pathways , including a <extra_id_0> p38 MAPK <extra_id_2> Protein <extra_id_1> inhibitor , SB203580 , or the <extra_id_0> GSK3beta <extra_id_2> Protein <extra_id_1> inhibitor , CT99021 ( Bain etal . , 2007 ) , no effect on <extra_id_0> IL-10 <extra_id_2> Protein <extra_id_1> production was observed ( FigureS5B ) .", "Upon addition of inhibitors to othersignaling pathways , including a p38 MAPK <extra_id_0> inhibitor <extra_id_2> Negative_regulation <extra_id_1> , SB203580 , or the GSK3beta <extra_id_0> inhibitor <extra_id_2> Negative_regulation <extra_id_1> , CT99021 ( Bain etal . , 2007 ) , no <extra_id_0> effect <extra_id_2> Regulation <extra_id_1> on IL-10 <extra_id_0> production <extra_id_2> Gene_expression <extra_id_1> was observed ( FigureS5B ) ."], "relation": [["Upon addition of inhibitors to othersignaling pathways , including a p38 MAPK <extra_id_0> inhibitor <extra_id_2> Negative_regulation <extra_id_1> , SB203580 , or the GSK3beta inhibitor , CT99021 ( Bain etal . , 2007 ) , no effect on IL-10 production was observed ( FigureS5B ) .", "Upon addition of inhibitors to othersignaling pathways , including a <extra_id_0> p38 MAPK <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> inhibitor , SB203580 , or the GSK3beta inhibitor , CT99021 ( Bain etal . , 2007 ) , no effect on IL-10 production was observed ( FigureS5B ) ."], ["Upon addition of inhibitors to othersignaling pathways , including a p38 MAPK inhibitor , SB203580 , or the GSK3beta <extra_id_0> inhibitor <extra_id_2> Negative_regulation <extra_id_1> , CT99021 ( Bain etal . , 2007 ) , no effect on IL-10 production was observed ( FigureS5B ) .", "Upon addition of inhibitors to othersignaling pathways , including a p38 MAPK inhibitor , SB203580 , or the <extra_id_0> GSK3beta <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> inhibitor , CT99021 ( Bain etal . , 2007 ) , no effect on IL-10 production was observed ( FigureS5B ) ."], ["Upon addition of inhibitors to othersignaling pathways , including a p38 MAPK inhibitor , SB203580 , or the GSK3beta inhibitor , CT99021 ( Bain etal . , 2007 ) , no <extra_id_0> effect <extra_id_2> Regulation <extra_id_1> on IL-10 production was observed ( FigureS5B ) .", "Upon addition of inhibitors to othersignaling pathways , including a p38 MAPK <extra_id_0> inhibitor <extra_id_2> Negative_regulation <extra_id_2> Cause <extra_id_1> , SB203580 , or the GSK3beta <extra_id_0> inhibitor <extra_id_2> Negative_regulation <extra_id_2> Cause <extra_id_1> , CT99021 ( Bain etal . , 2007 ) , no effect on IL-10 <extra_id_0> production <extra_id_2> Gene_expression <extra_id_2> Theme <extra_id_1> was observed ( FigureS5B ) ."], ["Upon addition of inhibitors to othersignaling pathways , including a p38 MAPK inhibitor , SB203580 , or the GSK3beta inhibitor , CT99021 ( Bain etal . , 2007 ) , no effect on IL-10 <extra_id_0> production <extra_id_2> Gene_expression <extra_id_1> was observed ( FigureS5B ) .", "Upon addition of inhibitors to othersignaling pathways , including a p38 MAPK inhibitor , SB203580 , or the GSK3beta inhibitor , CT99021 ( Bain etal . , 2007 ) , no effect on <extra_id_0> IL-10 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> production was observed ( FigureS5B ) ."]]}
{"trigger": ["Our data thus suggested that <extra_id_0> IL-10 <extra_id_2> Protein <extra_id_1> production by Th1 cells in response to high antigen dose and <extra_id_0> IL-12 <extra_id_2> Protein <extra_id_1> requires <extra_id_0> ERK1 <extra_id_2> Protein <extra_id_1> and <extra_id_0> ERK2 <extra_id_2> Protein <extra_id_1> signaling , but not the activation of the <extra_id_0> p38 <extra_id_2> Protein <extra_id_1> or the <extra_id_0> GSK3beta <extra_id_2> Protein <extra_id_1> pathways .", "Our data thus suggested that IL-10 <extra_id_0> production <extra_id_2> Gene_expression <extra_id_1> by Th1 cells <extra_id_0> in response to <extra_id_2> Positive_regulation <extra_id_1> high antigen dose and IL-12 <extra_id_0> requires <extra_id_2> Positive_regulation <extra_id_1> ERK1 and ERK2 signaling , but not the <extra_id_0> activation <extra_id_2> Positive_regulation <extra_id_1> of the p38 or the GSK3beta pathways ."], "relation": [["Our data thus suggested that IL-10 <extra_id_0> production <extra_id_2> Gene_expression <extra_id_1> by Th1 cells in response to high antigen dose and IL-12 requires ERK1 and ERK2 signaling , but not the activation of the p38 or the GSK3beta pathways .", "Our data thus suggested that <extra_id_0> IL-10 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> production by Th1 cells in response to high antigen dose and IL-12 requires ERK1 and ERK2 signaling , but not the activation of the p38 or the GSK3beta pathways ."], ["Our data thus suggested that IL-10 production by Th1 cells <extra_id_0> in response to <extra_id_2> Positive_regulation <extra_id_1> high antigen dose and IL-12 requires ERK1 and ERK2 signaling , but not the activation of the p38 or the GSK3beta pathways .", "Our data thus suggested that IL-10 <extra_id_0> production <extra_id_2> Gene_expression <extra_id_2> Theme <extra_id_1> by Th1 cells in response to high antigen dose and <extra_id_0> IL-12 <extra_id_2> Protein <extra_id_2> Cause <extra_id_1> requires ERK1 and ERK2 signaling , but not the activation of the p38 or the GSK3beta pathways ."], ["Our data thus suggested that IL-10 production by Th1 cells in response to high antigen dose and IL-12 <extra_id_0> requires <extra_id_2> Positive_regulation <extra_id_1> ERK1 and ERK2 signaling , but not the activation of the p38 or the GSK3beta pathways .", "Our data thus suggested that IL-10 production by Th1 cells <extra_id_0> in response to <extra_id_2> Positive_regulation <extra_id_2> Theme <extra_id_1> high antigen dose and IL-12 requires ERK1 and ERK2 signaling , but not the <extra_id_0> activation <extra_id_2> Positive_regulation <extra_id_2> Cause <extra_id_1> activation <extra_id_2> Positive_regulation <extra_id_2> Cause <extra_id_1> of the p38 or the GSK3beta pathways ."], ["Our data thus suggested that IL-10 production by Th1 cells in response to high antigen dose and IL-12 requires ERK1 and ERK2 signaling , but not the <extra_id_0> activation <extra_id_2> Positive_regulation <extra_id_1> of the p38 or the GSK3beta pathways .", "Our data thus suggested that IL-10 production by Th1 cells in response to high antigen dose and IL-12 requires ERK1 and ERK2 signaling , but not the activation of the <extra_id_0> p38 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> or the <extra_id_0> GSK3beta <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> pathways ."]]}
